SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-007940
Filing Date
2024-01-26
Accepted
2024-01-26 16:15:18
Documents
2
Period of Report
2024-01-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4162
2 EX-24 mreo-ex24.htm EX-24 16761
  Complete submission text file 0000950170-24-007940.txt   22486
Mailing Address C/O ALBIREO PHARMA INC. 50 MILK ST. 16TH FLOOR BOSTON MA 02109
Business Address
Sermon Charles (Reporting) CIK: 0001687318 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38452 | Film No.: 24567924

Mailing Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF
Business Address ONE CAVENDISH PLACE FOURTH FLOOR LONDON X0 W1G0QF 4403330237300
Mereo BioPharma Group plc (Issuer) CIK: 0001719714 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)